Predictive and prognostic factors for non-small cell lung cancer--potholes in the road to the promised land.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. The interplay of cancer-associated fibroblasts and apoptotic cancer cells suppresses lung cancer cell growth through WISP-1-integrin ανβ3-STAT1 signaling pathway.Cell communication and signaling : CCS · 2025
   Article
2. Survival analysis and factors affecting survival in patients who presented to the medical oncology unit with non-small cell lung cancerTurkish journal of medical sciences · 2020
   Article
3. Transforming growth factor β-induced epithelial-to-mesenchymal signature predicts metastasis-free survival in non-small cell lung cancer.Oncotarget · 2019
   Article
4. Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer.The oncologist · 2016
   Article
5. Precision medicine for cancer patients: lessons learned and the path forward.Journal of the National Cancer Institute · 2013
   Article
6. The evolving role of the pathologist in the management of lung cancer.Lung cancer management
   Article

Corrections and comments

• Comment on
  Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.2011

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as